These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
47. [Experimental studies on a new anticonvulsant]. KRUSHINSKII LV; SEREISKII MIa; PUSHKARSKAIA LP; FEDOROVA GI Zh Vyssh Nerv Deiat Im I P Pavlova; 1955; 5(6):892-900. PubMed ID: 13301034 [No Abstract] [Full Text] [Related]
48. Methods of evaluation of new anticonvulsant compounds. MILLICHAP JG Neurology; 1956 Jul; 6(7):484-90. PubMed ID: 13334756 [No Abstract] [Full Text] [Related]
50. Introduction: symposium on laboratory evaluation of antiepileptic drugs. Goodman LS Epilepsia; 1969 Jun; 10(2):105-6. PubMed ID: 5257107 [No Abstract] [Full Text] [Related]
51. [The side-effects of anti-epileptics]. LUELLMANN H Arzneimittelforschung; 1962 Aug; 12():868-73. PubMed ID: 14467217 [No Abstract] [Full Text] [Related]
52. [Pharmacological study of 5-5-diphenyl-tetrahydroglyoxaline-4-one. II. Toxicity and side effects]. GOODMAN L; CAHEN R Therapie; 1959; 14(1):117-25. PubMed ID: 13647428 [No Abstract] [Full Text] [Related]
53. Pharmacodynamic analysis of the anticonvulsant effects of tiagabine and lamotrigine in combination in the rat. Jonker DM; Voskuyl RA; Danhof M Epilepsia; 2004 May; 45(5):424-35. PubMed ID: 15101823 [TBL] [Abstract][Full Text] [Related]
54. Interactions of 1-methyl-1,2,3,4-tetrahydroisoquinoline with lamotrigine, oxcarbazepine, pregabalin, and topiramate in the mouse maximal electroshock-induced seizure model: a type I isobolographic analysis. Luszczki JJ; Antkiewicz-Michaluk L; Raszewski G; Czuczwar SJ Epilepsy Res; 2010 May; 89(2-3):207-19. PubMed ID: 20117917 [TBL] [Abstract][Full Text] [Related]